Why the study?
To unravel the structure-function relationships of TIX-5, a tick anticoagulant protein that specifically inhibits FXa-mediated activation of FV.
Elucidation of the structure-function properties of TIX-5 reveals three key interaction sites essential for its inhibition of FXa-mediated FV activation, providing insights into the initiation phase of blood coagulation.
No takes yet. Share an insight, caveat, or question.
TIX-5 sites should not change practice; leaves open targeted FXa-FV inhibition for future anticoagulants.
Maag et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: